Occurrence of lysophosphatidic acid and its alkyl ether-linked analog in rat brain and comparison of their biological activities toward cultured neural cells

Biochimica et Biophysica Acta - Molecular and Cell Biology of Lipids

Volumn 1440, Issue 2-3, 1999, Pages 194-204

  Sugiura, Takayuki ^a   Nakane, Shinji ^a   Kishimoto, Seishi ^a   Waku, Keizo ^a   Yoshioka, Yasuko ^b   Tokumura, Akira ^b   Hanahan, Donald J ^c  

^a TEIKYO UNIVERSITY   (Japan)

^b UNIVERSITY OF TOKUSHIMA   (Japan)

^c UNIVERSITY OF TEXAS HEALTH SCIENCE CENTER AT SAN ANTONIO   (United States)

Author keywords

Alkyl ether linked lysophospholipid; Brain, rat; Ca2+ transient; GC MS analysis; Lysophosphatidic acid; Platelet activating factor

Indexed keywords

ALKYL ETHER; LYSOPHOSPHATIDIC ACID; THROMBOCYTE ACTIVATING FACTOR;

ANIMAL EXPERIMENT; ANIMAL TISSUE; ARTICLE; BRAIN NERVE CELL; CELL CULTURE; CONTROLLED STUDY; DRUG ACTIVITY; FAST ATOM BOMBARDMENT MASS SPECTROMETRY; GAS CHROMATOGRAPHY; MALE; MASS SPECTROMETRY; MORPHOLOGY; NONHUMAN; PRIORITY JOURNAL; RAT; SIGNAL TRANSDUCTION;

EID: 0032834470     PISSN: 13881981     EISSN: None     Source Type: Journal    
DOI: 10.1016/S1388-1981(99)00127-4     Document Type: Article

References (45)

1. Gaits F., Fourcade O., Le Balle F., Gueguem G., Gaige B., Gassama-Diagne A., Fauvel J., Salles J.-P., Mauco G., Simon M.-F., Chap H. Lysophosphatidic acid as a phospholipid mediator: pathways of synthesis. FEBS Lett. 410:1997;54-58.
2. R.L. Wykle, F. Snyder, Microsomal enzymes involved in the metabolism of ether-linked glycerolipids and their precursors in mammals, in: A. Martonosi (Ed.), The Enzymes of Biological Membranes, Vol. 2, Plenum Press, New York, 1976, pp. 87-117.
3. Jalink K., Hordijk P.L., Moolenaar W.H. Growth factor-like effects of lysophosphatidic acid, a novel lipid mediator. Biochim. Biophys. Acta. 1198:1994;185-196.
4. Moolenaar W.H. Lysophosphatidic acid, a multifunctional phospholipid messenger. J. Biol. Chem. 270:1995;12949-12952.
5. Tokumura A. A family of phospholipid autacoids: occurrence, metabolism and bioactions. Prog. Lipid Res. 34:1995;151-184.
6. M.E. Durieux, Lysophosphatidate Signaling. Cellular Effects and Molecular Mechanisms, Spring-Verlag, Heidelberg, 1995, pp. 1-241.
7. Tokumura A., Fukuzawa K., Akamatsu Y., Yamada S., Suzuki T., Tsukatani H. Identification of vasopressor phospholipid in crude soybean lecithin. Lipids. 13:1978;468-472.
8. Tokumura A., Fukuzawa K., Tsukatani H. Contractile actions of lysophosphatidic acids with a chemically-defined fatty acyl group on longitudinal muscle from guinea-pig ileum. J. Pharm. Pharmacol. 34:1982;514-516.
9. Schumacher K.A., Classen H.G., Spath M. Platelet aggregation evoked in vitro and in vivo by phosphatidic acids and lysoderivatives: identity with substances in aged serum (DAS). Thromb. Haemost. 42:1979;631-640.
10. Gerrard J.M., Kindom S.E., Peterson D.A., Peller J., Krantz K.E., White J.G. Lysophosphatidic acid. Influence on platelet aggregation and intracellular calcium flux. Am. J. Pathol. 96:1979;423-438.
11. Tokumura A., Fukuzawa K., Isobe J., Tsukatani H. Lysophosphatidic acid-induced aggregation of human and feline platelets: structure-activity relationship. Biochem. Biophys. Res. Commun. 99:(1981):1981;391-398.
12. Simon M.F., Chap H., Douste-Blazy L. Human platelet aggregation induced by 1-alkyl-lysophosphatidic acid and its analogs: a new group of phospholipid mediators? Biochem. Biophys. Res. Commun. 108:1982;1743-1750.
13. Tokumura A., Yoshida J., Maruyama T., Fukuzawa K., Tsukatani H. Platelet aggregation induced by ether-linked phospholipids. 1. Inhibitory actions of bovine serum albumin and structural analogues of platelet activating factor. Thromb. Res. 46:1987;51-63.
14. Sugiura T., Tokumura A., Gregory L., Nouchi T., Weintraub S.T., Hanahan D.J. Biochemical characterization of the interaction of lipid phosphoric acids with human platelets: comparison with platelet-activating factor. Arch. Biochem. Biophys. 311:1994;358-368.
15. 2 and C and protein tyrosine phosphorylation in human platelets. Arch. Biochem. Biophys. 336:1996;59-68.
16. van Corven E.J., Groenink A., Jalink K., Eichholtz T., Moolenaar W.H. Lysophosphatidate-induced cell proliferation: identification and dissection of signaling pathways mediated by G proteins. Cell. 59:1989;45-54.
17. van Corven E.J., van Rijswijk A., Jalink K., van der Bend R.L., van Blitterswijk W.J., Moolenaar W.H. Mitogenic action of lysophosphatidic acid and phosphatidic acid on fibroblasts. Biochem. J. 281:1992;163-169.
18. Tigyi G., Miledi R. Lysophosphatidates bound to serum albumin activate membrane currents in Xenopus oocytes and neurite retraction in PC 12 pheochromocytoma cells. J. Biol. Chem. 267:1992;21360-21367.
19. Jalink K., Eichholtz T., Postma F.R., van Corven E.J., Moolenaar W.H. Lysophosphatidic acid induces neuronal shape changes via a novel, receptor-mediated signaling pathway: similarity to thrombin action. Cell Growth Differ. 4:1993;247-255.
20. 2 in noradrenaline release from cerebral cortical synaptosomes. J. Pharm. Pharmacol. 41:1989;450-458.
21. Imamura F., Horai T., Mukai M., Shinki K., Sawada M., Akedo H. Induction of in vitro tumor cell invasion of cellular monolayers by lysophosphatidic acid or phospholipase D. Biochem. Biophys. Res. Commun. 193:1993;497-503.
22. Kobayashi T., Yamano S., Murayama S., Ishikawa H., Tokumura A., Aono T. Effect of lysophosphatidic acid on the preimplantation development of mouse embryos. FEBS Lett. 351:1994;38-40.
23. Hecht J.H., Weiner J.A., Post S.R., Chun J. Ventricular zone gene-1 (vzg-1) encodes a lysophosphatidic acid receptor expressed in neurogenic regions of the developing cerebral cortex. J. Cell Biol. 135:1996;1071-1083.
24. An S., Dickens M.A., Bleu T., Hallmark O.G., Goetzl E.J. Molecular cloning of the human Edg2 protein and its identification as a functional cellular receptor for lysophosphatidic acid. Biochem. Biophys. Res. Commun. 231:1997;619-622.
25. Guo Z., Liliom K., Fischer D.J., Bathurst I.C., Tomei L.D., Kiefer M.C., Tigyi G. Molecular cloning of a high-affinity receptor for the growth factor-like lipid mediator lysophosphatidic acid from Xenopus oocytes. Proc. Natl. Acad. Sci. USA. 93:1996;14367-14372.
26. An S., Bleu T., Hallmark O.G., Goetzl E.J. Characterization of a novel subtype of human G protein-coupled receptor for lysophosphatidic acid. J. Biol. Chem. 273:1998;7906-7910.
27. Tigyi G., Henschen A., Miledi R. A factor that activates oscillatory chloride currents in Xenopus oocytes copurifies with a subfraction of serum albumin. J. Biol. Chem. 266:1991;20602-20609.
28. Tigyi G., Dyer D., Matute C., Miledi R. A serum factor that activates the phosphatidylinositol phosphate signaling system in Xenopus oocytes. Proc. Natl. Acad. Sci. USA. 87:1990;1521-1525.
29. Das A.K., Hajra A.K. Quantification, characterization and fatty acid composition of lysophosphatidic acid in different rat tissues. Lipids. 24:1989;329-333.
30. Snyder F. Platelet-activating factor and its analogs: metabolic pathways and related intracellular processes. Biochim. Biophys. Acta. 1254:1995;231-249.
31. T. Sugiura, K. Waku, Biosynthesis of platelet-activating factor and structurally related bioactive lipids, in: D.H.R Barton, K. Nakanishi (Eds.), Comprehensive Natural Product Chemistry, Vol. 1, Elsevier, Oxford, 1999, pp. 285-302.
32. Bligh E.G., Dyer W.J. A rapid method of total lipid extraction and purification. Can. J. Biochem. Physiol. 37:1959;911-917.
33. Tokumura A., Harada K., Yoshioka Y., Tsukatani H., Handa Y. Analyses of lysophosphatidic acids by gas chromatography mass spectrometry without hydrolytic pretreatment. Biomed. Mass Spectrom. 11:1984;167-171.
34. 2+ in neuroblastoma×glioma hybrid NG108-15 cells. Biochem. Biophys. Res. Commun. 229:1996;58-64.
35. Tokumura A., Yoshioka Y., Tsukatani H., Handa Y. Gas chromatographic/mass spectrometric analyses of ether-linked lysophosphatidic acid and its analogues. Biomed. Environ. Mass Spectrom. 13:1986;175-180.
36. Liliom K., Guan Z., Tseng J.-L., Desiderio D.M., Tigyi G., Watsky M.A. Growth factor-like phospholipids generated after corneal injury. Am. J. Physiol. 274:1998;C1065-C1074.
37. Tokumura A., Nishioka Y., Yoshimoto O., Shinomiya J., Fukuzawa K. Substrate specificity of lysophospholipase D which produces bioactive lysophosphatidic acids in rat plasma. Biochim. Biophys. Acta. 1437:1999;235-245.
38. Das A.K., Hajra A.K. Estimation of acyldihydroxyacetone phosphate and lysophosphatidate in animal tissues. Biochim. Biophys. Acta. 796:1984;178-189.
39. Liliom K., Fischer D.J., Virag T., Sun G., Miller D.D., Tseng J.-L., Desiderio D.M., Seidel M.C., Erickson J.R., Tigyi G. Identification of a novel growth factor-like lipid, 1-O-cis-alk-1′-enyl-2-lyso-sn-glycero-3-phosphate (alkenyl-GP) that is present in commercial sphingolipid preparations. J. Biol. Chem. 273:1998;13461-13468.
40. W.E.M. Lands, C.G. Crawford, Enzymes of membrane phospholipid metabolism in animals, in: A. Martonosi (Ed.), The Enzymes of Biological Membranes, Vol. 2, Plenum Press, New York, 1976, pp. 3-85.
41. Sugiura T., Kondo S., Sukagawa A., Nakane S., Shinoda A., Itoh K., Yamashita A., Waku K. 2-Arachidonoylglycerol: a possible endogenous cannabinoid receptor ligand in brain. Biochem. Biophys. Res. Commun. 215:1995;89-97.
42. Stella N., Schweitzer P., Piomelli D. A second endogenous cannabinoid that modulates long-term potentiation. Nature. 388:1997;773-778.
43. 2+-dependent and -independent mechanisms. FEBS Lett. 429:1998;152-156.
44. Liliom K., Murakami-Murofushi K., Kobayashi S., Murofushi H., Tigyi G. Xenopus oocytes express multiple receptors for LPA-like lipid mediators. Am. J. Physiol. 270:1996;C772-C777.
45. Fischer D.J., Liliom K., Guo Z., Nusser N., Virag T., Murakami-Murofushi K., Kobayashi S., Erickson J.R., Sun G., Miller D.D., Tigyi G. Naturally occurring analogs of lysophosphatidic acid elicit different cellular responses through selective activation of multiple receptor subtypes. Mol. Pharmacol. 54:1998;979-988.